| Literature DB >> 27784078 |
Khaled Ezzedine1, Maxine Whitton2, Mariona Pinart3.
Abstract
Clinical Question: Which interventions are associated with highest efficacy and fewest adverse events for treating vitiligo? Bottom Line: Combination therapies, particularly those involving some form of light (ie, narrowband UV-B) were associated with more improved repigmentation than monotherapies. There was limited evidence to support the association of UV-A alone and UV-B alone with repigmentation for vitiligo. There was moderate evidence to support the association of UV-A and UV-B, when used in combination with psoralens, topical corticosteroids, vitamin D analogues, fluorouracil, azathioprine, and oral prednisolone with improved outcomes for vitiligo. However, combination therapies were associated with more adverse effects.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27784078 DOI: 10.1001/jama.2016.12399
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272